Intellect Design Arena (INTELLECT) near Rs 505: Is the 16% share-price crash justified when AI revenue is growing but profits are not?
Read More Pharma Industry News Orchid Pharma secures USFDA approval, reinforcing global leadership in sterile cephalosporins Orchid Pharma Limited has reaffirmed its position as a leading pharmaceutical manufacturer with the successful completion of a… byPallavi MadhirajuFebruary 20, 2025